PHARMACORD
LIVE

Serial Number

87236919

Owner

PharmaCord LLC

Attorney

Trevor T. Graves

First Use Date

Oct 1, 2018

Filing Date

Nov 15, 2016

Add to watchlist:

No watchlists yet
View on USPTO

PHARMACORD Trademark

Serial Number: 87236919 • Registration: 5782112

PHARMACORD is a trademark filed by PharmaCord LLC on November 15, 2016. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PharmaCord LLC (2 trademarks)

6100 Dutchmans Lane, Suite 601
Louisville, KY 40205

Entity Type: 16

Trademark Details

Filing Date

November 15, 2016

Registration Date

June 18, 2019

First Use Anywhere

October 1, 2018

First Use in Commerce

October 1, 2018

Published for Opposition

August 29, 2017

Goods & Services

Personal lifestyle consulting services; Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication; Providing emotional counseling and emotional support services for medical patients

Educational services, namely, conducting programs in the fields of drug therapy, side effect management, lifestyle management, disease state management and proper administration of medication; Educational services, namely, providing clinical support programs regarding drug therapy, side effect management, disease state management and proper administration of medication

Claims administration services in the field of health insurance, namely, administration and coordination of healthcare assignment of benefits for others and verification of patient eligibility for health- and prescription-benefits coverage of pharmaceuticals; Financial administration of patient reimbursement programs; Financial management of reimbursement payments for others

Market analysis services in the field of specialty drug commercialization; Business consulting services relating to product distribution and operations management in the field of new specialty drugs; Patient relationship management services; Business consulting services relating to the operation of quick start and interim care programs; Management services provided to pharmaceutical manufacturers for controlling drug inventories; Healthcare business administration services, namely, administering patient reimbursement programs and administering pharmacy reimbursement programs; Business management in the field of patient assistance programs, prescription drugs and new specialty drugs

Data warehousing services; Database development services, namely, collecting and maintaining patient information and registry data; Database development services, namely, customized data collection and maintaining related databases in the field of prescription drugs; Software as a service (SAAS) services, namely, hosting software for use by others for the purpose of connecting clinical programs with specialty drug manufacturers, and managing inventory, billing and account receivables, as well as shipping and reporting, master patient data aggregation and analysis, and call center services; Developing customized software for others for the purpose of connecting clinical programs with specialty drug manufacturers, and managing inventory, billing and account receivables, as well as managing shipping and reporting, master patient data aggregation and analysis, and call center services

Medical counseling in the field of drug therapy, side effect management, disease state management and proper administration of medication; Pharmaceutical consultation in the field of new specialty drugs; Providing information to patients in the field of administering medications; Providing medical information to patients; Patient health care counseling and advice regarding products in the field of prescription drugs; Providing information in the field of prescription drugs distributed via the Internet

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 17, 2026 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 17, 2026 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 17, 2026 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 15, 2025 E815
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 19, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 19, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 19, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 19, 2025 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 10, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 10, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 10, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 10, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 10, 2024 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 18, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 18, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 14, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 13, 2019 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 30, 2019 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Apr 29, 2019 SUPC
SOU EXTENSION 3 GRANTED
Apr 29, 2019 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 29, 2019 AITU
USE AMENDMENT FILED
Apr 23, 2019 IUAF
SOU EXTENSION 3 FILED
Apr 23, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 23, 2019 EEXT
TEAS STATEMENT OF USE RECEIVED
Apr 23, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 25, 2018 EXRA
SOU EXTENSION 2 GRANTED
Oct 23, 2018 EX2G
SOU EXTENSION 2 FILED
Oct 23, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 23, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 26, 2018 EXRA
SOU EXTENSION 1 GRANTED
Apr 24, 2018 EX1G
SOU EXTENSION 1 FILED
Apr 24, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 24, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 24, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 29, 2017 NPUB
PUBLISHED FOR OPPOSITION
Aug 29, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 9, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 21, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 21, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 21, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 21, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 21, 2017 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 5, 2017 GNFN
FINAL REFUSAL E-MAILED
Jul 5, 2017 GNFR
FINAL REFUSAL WRITTEN
Jul 5, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2017 TEME
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 16, 2017 PARI
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 12, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 12, 2017 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 22, 2017 GNRN
NON-FINAL ACTION E-MAILED
Feb 22, 2017 GNRT
NON-FINAL ACTION WRITTEN
Feb 22, 2017 CNRT
ASSIGNED TO EXAMINER
Feb 22, 2017 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Nov 22, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 21, 2016 NWOS
NEW APPLICATION ENTERED
Nov 18, 2016 NWAP